SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin concludes acquisition of 100% equity stake in Lab Grin

04 Oct 2014 Evaluate

Lupin has completed acquisition of 100% equity stake in Laboratorios Grin, S.A. De C.V., Mexico (Lab Grin) on September 30, 2014. Consequent to which, Lab Grin has become a wholly-owned subsidiary of the company with effect from September 30, 2014.

This acquisition marks the pharma major’s foray into the high growth Mexican and the larger Latin American pharmaceuticals market. Mexico is one of the fastest growing pharmaceutical markets in the world valued at over $13.5 billion and growing at 9-10% annually.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2399.65 3.15 (0.13%)
02-Jul-2026 13:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.65
Dr. Reddys Labs. 1359.85
Cipla 1459.80
Zydus Lifesciences 1099.00
Lupin 2399.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: